Rheumatoid Arthritis
Showing NaN - NaN of 106
Rheumatoid Arthritis (RA) Trial in Worldwide (NI-071, Infliximab)
Completed
- Rheumatoid Arthritis
-
Little Rock, Arkansas
- +133 more
Jan 26, 2023
Rheumatoid Arthritis Trial in Worldwide (Filgotinib, Placebo to match filgotinib)
Active, not recruiting
- Rheumatoid Arthritis
- Filgotinib
- Placebo to match filgotinib
-
Huntsville, Alabama
- +344 more
Oct 20, 2022
Rheumatoid Arthritis Trial in Worldwide (Methotrexate, Upadacitinib, Placebo Upadacitinib)
Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Pneumococcal 13-valent conjugate vaccine (PCV-13))
Completed
- Rheumatoid Arthritis
- Upadacitinib
- Pneumococcal 13-valent conjugate vaccine (PCV-13)
-
Huntsville, Alabama
- +123 more
Jun 15, 2022
Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)
Active, not recruiting
- Rheumatoid Arthritis
- Placebo for Adalimumab
- +3 more
-
Birmingham, Alabama
- +369 more
Jun 14, 2022
Rheumatoid Arthritis Trial in Worldwide (MSB11456, EU-approved RoActemra)
Completed
- Rheumatoid Arthritis
- MSB11456
- EU-approved RoActemra
-
Haskovo, Khaskovo, Bulgaria
- +81 more
Jun 20, 2022
Rheumatoid Arthritis Trial in Worldwide (ABX464 50mg, Matching Placebo, ABX464 100mg)
Completed
- Rheumatoid Arthritis
- ABX464 50mg
- +3 more
-
Bruxelles, Belgium
- +23 more
Feb 3, 2022
Rheumatoid Arthritis Trial in Worldwide (SAR153191 (REGN88))
Completed
- Rheumatoid Arthritis
- SAR153191 (REGN88)
-
Anniston, Alabama
- +334 more
Mar 21, 2022
Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Adalimumab, Placebo (for sarilumab))
Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Placebo)
Rheumatoid Arthritis Trial in Worldwide (BMS-945429 Placebo, BMS-945429, Methotrexate)
Completed
- Rheumatoid Arthritis
- BMS-945429 Placebo
- +5 more
-
Peoria, Arizona
- +99 more
Dec 3, 2021
Rheumatoid Arthritis Trial in Worldwide (Olokizumab, Placebo)
Rheumatoid Arthritis Trial in Worldwide (Abatacept, Methotrexate, Abatacept Placebo)
Rheumatoid Arthritis Trial in Worldwide (Filgotinib, Placebo to match filgotinib, MTX)
Rheumatoid Arthritis Trial in Worldwide (Filgotinib, Placebo to match filgotinib, csDMARDs)
Rheumatoid Arthritis Trial in Worldwide (Olokizumab 64mg q4w, Olokizumab 64mg q2w, Adalimumab 40mg q2w)
Completed
- Rheumatoid Arthritis
- Olokizumab 64mg q4w
- +3 more
-
Mesa, Arizona
- +244 more
Apr 6, 2021